Utility of magnetic resonance imaging with contrast enhancementin patients with cardiac arrhythmias: a cardiologist’s view
Authors:
Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery; Rublevskoe shosse, 135, Moscow, 121552, Russian Federation
Keywords: magnetic resonance imaging late gadolinium enhancement heart rhythm disorders atrial fibrillation ventricular tachycardia sudden cardiac death
Abstract
Magnetic resonance imaging (MRI) is one of the most informative methods of detailed assessment of myocardial tissue in vivo. Since the 90-ies of XX century in clinical practice firmly established technique of the late gadolinium enhancement (LGE). LGE is associated with adverse clinical outcomes across a range of different cardiac conditions and may improve risk stratification for death, sudden cardiac death, or serious adverse events beyond traditional prognostic markers. In recent years performed the analysis of diagnostic and prognostic impact of LGE in patients with cardiac arrhythmias. This article presents the current literature review of the MRI with LGE in patients with ischemic heart disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, myocardial inflammatory diseases, non-valvular atrial fibrillation and selection of patients for cardioverter-defibrillator implantation using MRI.References
1. Geva T. Magnetic resonance imaging: historical perspective. J. Cardiovasc. Magn. Reson. 2006; 8 (4): 573–80.2. Синицын В.Е., Стукалова О.В., Ларина О.М., Тер- новой С.К. Новые возможности диагностики не- коронарогенных поражений миокарда: роль магнитно-резонансной томографии. Креатив- ная кардиология. 2008; 1: 66–73.
3. Ларина О.М. Диагностическое значение магнит- но-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза. Литературный обзор. Вестник Российского научно- го центра рентгенорадиологии Минздрава России. 2010; 10. Available at: http://vestnik.rncrr.ru/vestnik/ v10/papers/larina_v10.htm.
4. Шомахов Р.А., Макаренко В.Н., Бокерия Л.А. Эволюция методов диагностики и прогнозиро- вания некоронарогенных желудочковых арит- мий. Креативная кардиология. 2014; 2: 36–47.
5. Lipinski M.J., McVey C.M., Berger J.S. et al. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and metaanalysis. J. Am. Coll. Cardiol. 2013; 62 (9): 826–38.
6. Бокерия О.Л., Биниашвили М.Б. Внезапная сер- дечная смерть и ишемическая болезнь сердца. Анналы аритмологии. 2013; 10 (2): 69–79. DOI: 10.15275/annaritmol.2013.2.2.
7. Scott P.A., Rosengarten J.A., Curzen N.P., Morgan J.M. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur. J. Heart Fail. 2013; 15 (9): 1019–27.
8. White J.A., Fine N.M., Gula L. et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ. Cardiovasc. Imaging. 2012; 5 (1): 12–20.
9. Shi H.W., Pu P., Deng W., Zhou H. et al. Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis. Saudi Med. J. 2013; 34 (7): 719–26.
10. Kuruvilla S., Adenaw N., Katwal A.B. et al. Late Gadolinium Enhancement on CMR predicts adverse cardiovascular outcomes in non-ischemic cardiomyopathy: A systematic review and metaanalysis. Circ. Cardiovasc. Imaging. 2013. DOI: 10.1161/circimaging.113.001144.
11. Green J.J., Berger J.S., Kramer C.M., Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc. Imaging. 2012; 5 (4): 370–7.
12. Grьn S., Schumm J., Greulich S. et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J. Am. Coll. Cardiol. 2012; 59 (18): 1604–15.
13. Голухова Е.З. Внезапная сердечная смерть. Ме- няют ли результаты рандомизированных иссле- дований наши представления о возможных предикторах и путях профилактики? Креатив- ная кардиология. 2008; 1: 7–24.
14. Klem I., Weinsaft J.W., Bahnson T.D. et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J. Am. Coll. Cardiol. 2012; 60 (5): 408–20.
15. Клинические рекомендации по проведению электрофизиологических исследований, кате- терной абляции и применению имплантируе- мых антиаритмических устройств. Всероссий- ское научное общество специалистов по клини- ческой электрофизиологии, аритмологии и кардиостимуляции (ВНОА); 2013. Available at: http://www.vnoa.ru/upload/Recomend2013.pdf.
16. Бокерия Л.А., Шенгелия Л.Д. Механизмы фиб- рилляции предсердий: от идей и гипотез к эф фективному пониманию проблемы. Анналы аритмологии. 2014; 11 (1): 5–9. DOI: 10.15275/annaritmol.2014.1.1.
17. Peters D.C., Wylie J.V., Hauser T.H. et al. Recurrence of atrial fibrillation correlates with the extent of postprocedural late gadolinium enhancement: a pilot study. JACC Cardiovasc. Imaging. 2009; 2 (3): 308–16.
18. Akoum N., Fernandez G., Wilson B. et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 2013; 24 (10): 1104–9.
19. Akkaya M., Higuchi K., Koopmann M., Burgon N. et al. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace. 2013; 15 (12): 1725–32.
20. McGann C., Akoum N., Patel A. et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ. Arrhythm. Electrophysiol. 2014; 7 (1): 23–30.